XML 14 R4.htm IDEA: XBRL DOCUMENT v3.24.0.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Revenue $ 1,115 $ 263 $ 1,540 $ 301
Cost of revenue 583 155 825 187
Gross profit 532 108 715 114
Operating expenses:        
Selling, general and administrative 2,022 1,558 3,668 3,200
Research and development 1,578 1,364 3,450 2,492
Total operating expenses 3,600 2,922 7,118 5,692
Loss from operations (3,068) (2,814) (6,403) (5,578)
Other income and expense, net 427 396 850 631
Net loss $ (2,641) $ (2,418) $ (5,553) $ (4,947)
Weighted average common shares outstanding:        
Basic and diluted (in shares) 1,631 1,613 1,631 1,613
Basic and diluted net loss per common share:        
Net loss per common share (in dollars per share) $ (1.62) $ (1.5) $ (3.4) $ (3.07)
Other comprehensive loss, net of tax:        
Net loss $ (2,641) $ (2,418) $ (5,553) $ (4,947)
Available-for-sale securities:        
Net unrealized loss 325 (2) 270 (370)
Total comprehensive loss $ (2,316) $ (2,420) $ (5,283) $ (5,317)